{
    "en_vn": {
        "data": {
            "content": "<div class=\"dict--title\">T\u1eeb \u0111i\u1ec3n Anh - Vi\u1ec7t</div><div class=\"dict--content\"><table id=\"definition\" border=\"0\"><tr id=\"pa\"><td id=\"I_C\"><font color=\"#9e9e9e\">\u25d8</font></td><td id=\"C_C\" colspan=\"2\"><font color=\"#9e9e9e\">[m\u0259'lign\u0259nsi ]</font></td></tr><tr id=\"tl\"><td id=\"I_C\"><font color=\"#1a76bf\">*</font></td><td id=\"C_C\" colspan=\"2\"><b><font color=\"#1a76bf\">danh t\u1eeb</font></b></td></tr><tr id=\"mn\"><td>\u00a0</td><td id=\"I_C\"><font color=\"#999\">\u25a0</font></td><td id=\"C_C\">t\u00ednh th\u00e2m hi\u1ec3m</td></tr><tr id=\"mn\"><td>\u00a0</td><td id=\"I_C\"><font color=\"#999\">\u25a0</font></td><td id=\"C_C\">kh\u1ed1i u \u00e1c t\u00ednh</td></tr></table><i/></div>",
            "word": "malignancy"
        }
    },
    "en_en": {
        "data": {
            "content": "<div class=\"dict--title\">Anh - Anh</div><div class=\"dict--content\"><k>malignancy</k><blockquote><cclass>[<cclass>m\u0259'l\u026agn\u0259nsi<cclass>]</cclass></cclass></cclass></blockquote><blockquote>\u25a0 <cclass>noun (<cclass>plural <cclass><b>malignancies</b>) </cclass></cclass></cclass></blockquote><blockquote><blockquote>1\u300b the state or presence of a malignant tumour; cancer. </blockquote></blockquote><blockquote><blockquote>\u00a0\u00a0\u00a0\u00a0\u2043 a cancerous growth. </blockquote></blockquote><blockquote><blockquote>\u00a0\u00a0\u00a0\u00a0\u2043 a form of cancer. </blockquote></blockquote><blockquote><blockquote>2\u300b the quality of being malign. </blockquote></blockquote></div>",
            "word": "malignancy"
        }
    },
    "synonyms": {
        "data": {
            "content": null,
            "word": "malignancy"
        }
    },
    "grammar": {
        "data": {
            "content": null,
            "word": "malignancy"
        }
    },
    "specialist": {
        "data": {
            "content": null,
            "word": "malignancy"
        }
    },
    "sentences": [
        {
            "en": "The overgrowth is benign but <em>malignancy</em> may occur in any of the constituent tissue elements.",
            "vi": "T\u0103ng sinh n\u00e0y th\u01b0\u1eddng l\u00e0nh t\u00ednh nh\u01b0ng c\u0169ng c\u00f3 th\u1ec3 x\u1ea3y ra \u00e1c t\u00ednh trong b\u1ea5t k\u1ef3 y\u1ebfu t\u1ed1 c\u1ea5u th\u00e0nh n\u00e0o c\u1ee7a m\u00f4."
        },
        {
            "en": "It may be produced by carcinomas, particularly of the colon, and is a rather in sensitive marker of <em>malignancy</em>.",
            "vi": "N\u00f3 c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c t\u1ea1o th\u00e0nh b\u1edfi carcinoma \u0111\u1eb7c bi\u1ec7t \u1edf ru\u1ed9t gi\u00e0 v\u00e0 \u0111\u00fang h\u01a1n, n\u00f3 l\u00e0 m\u1ed9t ch\u1ea5t ch\u1ec9 s\u1ef1 \u00e1c t\u00ednh kh\u00f4ng nh\u1ea1y c\u1ea3m."
        },
        {
            "en": "Malignant fibrous histiocytoma (MFH) affects the soft tissues, including muscle, ligaments, tendons, and fat. It is the most common soft-tissue <em>malignancy</em> in later adult life, usually occurring in people 50-60 years of age. It most commonly affects the extremities and is about twice as common in males as females. MFH also has a wide range of severity. The overall five-year survival rate is about 35%-60%.",
            "vi": "U x\u01a1 da \u00e1c t\u00ednh (MFH) x\u1ea3y ra \u1edf c\u00e1c m\u00f4 m\u1ec1m, bao g\u1ed3m c\u01a1, d\u00e2y ch\u1eb1ng, g\u00e2n, v\u00e0 m\u1ee1. \u0110\u00e2y l\u00e0 ch\u1ee9ng b\u1ec7nh \u00e1c t\u00ednh \u1edf m\u00f4 m\u1ec1m th\u01b0\u1eddng th\u1ea5y nh\u1ea5t \u1edf giai \u0111o\u1ea1n cu\u1ed1i c\u1ee7a tu\u1ed5i tr\u01b0\u1edfng th\u00e0nh, th\u01b0\u1eddng g\u1eb7p \u1edf b\u1ec7nh nh\u00e2n t\u1eeb 50-60 tu\u1ed5i. B\u1ec7nh th\u01b0\u1eddng xu\u1ea5t hi\u1ec7n nhi\u1ec1u nh\u1ea5t \u1edf ch\u00e2n tay v\u00e0 t\u1ec9 l\u1ec7 m\u1eafc b\u1ec7nh \u1edf nam gi\u1edbi l\u00e0 ch\u1eebng g\u1ea5p \u0111\u00f4i so v\u1edbi ph\u1ee5 n\u1eef. C\u00f3 nhi\u1ec1u m\u1ee9c \u0111\u1ed9 u x\u01a1 da \u00e1c t\u00ednh kh\u00e1c nhau. T\u1ec9 l\u1ec7 s\u1ed1ng s\u00f3t n\u0103m n\u0103m n\u00f3i chung l\u00e0 kho\u1ea3ng 35% - 60%."
        },
        {
            "en": "Essential Screening Tests Every Woman Needs    Why screening tests are important Getting the right screening test at the right time is one of the most important things you can do for your health. Screenings find diseases like cancer or diabetes early, before you have symptoms, and when they\u2019re easier to treat. Which test you should have depends on your age and your risk factors. Learn more about the screenings your doctor may recommend for you.  Breast cancer Early detection of breast cancer greatly improves your odds for survival. That's because the smaller the cancer is when it's found, the better the chance for a surgical cure. Smaller breast cancers are also less likely to have spread to lymph nodes and other organs such as the lungs and brain. If you're in your 20s or 30s and do not have known breast cancer risk factors, a clinical breast exam by a health professional should be part of your regular health exam once every three years. Screening with mammography Talk to your doctor about breast cancer screening. The American Cancer Society recommends yearly screening for women at average risk beginning at 40. However, the U.S. Preventive Services Task Force recommends screening mammograms every two years from ages 50 to 74. These low-dose X-rays can detect a lump three years before you can feel it. But a normal mammogram does not completely rule out the possibility of breast cancer. Cervical cancer The cervix is the part of the uterus that extends into the vaginal cavity. Persistent infection with the human papillomavirus (HPV) is the major risk factor for cervical cancer. Routine screening can find it early, when it's highly curable. It can also find abnormal precancerous cells on the surface of the cervix so they can be removed before they turn into cancer. Screening for cervical cancer Doctors use a Pap test to screen for cancer of the cervix. In the office, the doctor collects a sample of cells from your cervix. These are examined in the lab to find precancerous and cancer cells. The screening test should start at age 21. It's very effective in both preventing and finding cervical cancer early enough to cure it. A vaccine for cervical cancer The FDA has approved a vaccine -- Gardasil -- for girls and women between the ages of 9 and 26. It confers immunity against four strains of HPV, the virus that is a leading cause of cervical cancer. A second vaccine, Cervarix, received FDA approval in October 2009 for use in girls and women between the ages of 10 and 25. Cervarix targets two strains of HPV. Not all cervical cancers are due to HPV and other strains of HPV can still cause cancer that neither vaccine protects against. So while these vaccines may greatly reduce the number of cervical cancer cases, it\u2019s still important to have routine Pap tests to screen for cancer of the cervix. Osteoporosis and fractured bones Osteoporosis is a condition in which bones become weak and fragile. It's caused by bone loss, which accelerates in women after menopause. The first symptom is often a painful bone fracture that can occur with only a minor fall, blow, or even just a twist of the body. It is possible to both prevent and treat osteoporosis, which threatens over half of U.S. adults aged 50 and over, according to the National Osteoporosis Foundation.  Osteoporosis screening tests A test called Dual Energy X-ray Absorptiometry (DXA) can measure bone mineral density and detect osteoporosis before fractures occur. It can also help predict the risk of future bone fractures. Bone density testing is recommended for all women 65 years of age and older. It's also recommended for middle-aged women younger than 65 who have risk factors for osteoporosis. Skin cancer The most dangerous form of skin cancer is melanoma. It's a <em>malignancy</em> that affects the cells that produce pigment in the skin. Some people may have a genetic risk factor for melanoma. And the risk increases with overexposure to the sun and sunburn. Early treatment of skin cancer can be effective. And melanomas that are detected at a thinner stage can be treated more successfully than thick ones that have grown deeper into the skin. Basal cell and squamous cell skin cancers are common non-melanoma skin cancers. Screening for skin cancer The American Cancer Society and the American Academy of Dermatology recommend regular skin self-exams to check for any changes in marks on your skin including shape, color, and size. A skin exam by a dermatologist or other health professional should be part of a routine cancer checkup. High blood pressure (Hypertension) Your risk for high blood pressure increases with age. It's also related to your weight and certain lifestyle habits. High blood pressure can lead to severe complications without any prior symptoms, including an aneurysm. But high blood pressure can be treated. When it is, you reduce your risk of complications such as heart disease, stroke, and kidney failure. The bottom line: Know your blood pressure. If it's high, work with your doctor to manage it. Screening for high blood pressure Blood pressure is expressed as two numbers. The first (systolic) is the pressure of your blood against your artery walls when the heart beats. The second (diastolic) is the pressure between beats. Normal adult blood pressure is less than 120/80. Blood pressure that is 140/90 or higher is considered high blood pressure. A reading between those two is considered prehypertension. How often blood pressure should be checked depends on how high it is and what other risk factors you have. Cholesterol levels A high level of LDL cholesterol is a major factor that increases the risk of developing heart disease and atherosclerosis -- hardening and narrowing of the arteries -- which is caused by plaque building up inside your arteries. It can progress without symptoms for many years. Over time it can lead to heart attack and stroke. Other atherosclerosis risk factors are high blood pressure, diabetes, and smoking. Lifestyle changes and medications can lower your risk of cardiovascular disease. Determining cholesterol levels Doctors screen for problems with cholesterol by using a fasting blood lipid panel. That's a blood test that tells you your levels of total cholesterol, LDL \"bad\" cholesterol, HDL \"good\" cholesterol, and triglyceride (blood fat). Management decisions are based on the results. For adults 20 years or older, you should have a new panel done at least every five years. Type 2 diabetes One-third of the people in the U.S. with diabetes don't know they have it. The sixth leading cause of death in the U.S., diabetes can lead to a vast array of complications such as heart disease and stroke, kidney disease, blindness from damage to the blood vessels of the retina, and nerve damage. But, especially when found early, diabetes can be controlled and complications avoided with diet, exercise, and weight loss. Screening for type 2 diabetes A test known as fasting plasma glucose is most often used to screen for diabetes and prediabetes. Blood is drawn after you've fasted at least eight hours and used to determine your blood sugar level. A level of 100 to 125 indicates prediabetes. And 126 or higher indicates diabetes. If you're healthy and have a normal risk of diabetes, you should have the test every three years starting at age 45. If you have a higher risk, you may start testing earlier and more frequently. Human Immunodeficiency Virus (HIV) HIV is the virus that causes AIDS. It's in the blood and other body secretions of infected individuals, even when there are no symptoms. It spreads from one person to another when these secretions coming in contact with the vagina, anal area, mouth, eyes, or a break in the skin. There is still no cure or vaccine. But, theoretically, early treatment with anti-HIV medications may help the body's immune system fight the virus. HIV screening tests HIV-infected individuals can remain symptom free for many years. The only way to know they are infected is with a series of blood tests. The first test is called ELISA or EIA. It looks for antibodies to HIV in the blood. It\u2019s possible not to be infected and still show positive on the test. So a second test called a Western blot assay is done for confirmation. If you were recently infected, you could still have a negative test result. Repeat testing is recommended. If you think you may have been exposed to HIV, ask your doctor about the tests. Preventing the spread of HIV Most newly infected individuals test positive by two months after infection. But up to 5% are still negative after six months. Abstinence or using latex barriers such as a condom or a dental dam is necessary to avoid potential infection of HIV and other sexually transmitted infections. If you have HIV and are pregnant, talk with your doctor about what needs to be done to reduce the risk of HIV infection in your unborn child. Colorectal cancer Colorectal cancer is the second common cause of death from cancer, and ranks third for women after lung and breast cancer. The majority of colon cancers develop from colon polyps that are growths on the inner surface of the colon. After cancer develops it can invade or spread to other parts of the body. The way to prevent colon cancer is to find and remove colon polyps before they turn cancerous. Screening for colorectal cancer A colonoscopy is a common screening test for colorectal cancer. A doctor views the entire colon using a flexible tube and a camera. Polyps can be removed at the time of the test. A similar alternative is a flexible sigmoidoscopy that examines only the lower part of the colon. If you are at average risk, screening usually starts at age 50. Glaucoma Glaucoma is a condition that can result in blindness due to damage to the optic nerve. Primary open angle glaucoma is the most common type. This glaucoma often produces no symptoms until it is too late and vision loss has begun. There is good evidence that treating elevated eye pressure in glaucoma can prevent blindness. Glaucoma screening How often you should have an eye exam that includes measuring the pressure inside the eye depends on your age and risk factors. African-Americans, people older than age 60, family history of glaucoma, personal history of eye injury, and steroid use are risk factors. For healthy individuals without increased risk, routine screening every two to four years is recommended for people under age 40. For those between 40 to 54 years, testing should be done every one to three years. From age 55 to 64, testing should be done every one to two years, and for those over 65, every six to 12 months. Importance of health screening Being proactive and discussing screening tests with your doctor makes good health sense. Some tests, such as a Pap test or breast exam should be a routine part of every woman's health care. Other tests become more or less important based on your risks. Proper screening won't always prevent a disease. But it can find a disease early enough to give you the best chance of overcoming it.",
            "vi": "C\u00e1c th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc c\u1ea7n thi\u1ebft \u0111\u1ed1i v\u1edbi ph\u1ee5 n\u1eef     T\u1ea1i sao th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc l\u1ea1i quan tr\u1ecdng Vi\u1ec7c ti\u1ebfn h\u00e0nh th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc h\u1ee3p l\u00fd, \u0111u\u0301ng lu\u0301c l\u00e0 m\u1ed9t trong nh\u1eefng \u0111i\u1ec1u quan tr\u1ecdng h\u00e0ng \u0111\u1ea7u trong vi\u1ec7c gi\u1eef g\u00ecn s\u1ee9c kh\u1ecfe. Th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc giu\u0301p t\u00ecm ra b\u1ec7nh nh\u01b0 ung th\u01b0 ho\u1eb7c ti\u1ec3u \u0111\u01b0\u1eddng s\u1edbm, tr\u01b0\u1edbc khi xu\u1ea5t hi\u1ec7n c\u00e1c tri\u1ec7u ch\u1ee9ng, v\u00e0 khi \u0111\u00f3 ng\u01b0\u1eddi ta c\u00f3 th\u1ec3 ch\u1eefa l\u00e0nh d\u1ec5 d\u00e0ng h\u01a1n. Tu\u1ed5i t\u00e1c v\u00e0 c\u00e1c y\u1ebfu t\u1ed1 r\u1ee7i ro v\u1ec1 s\u1ee9c kh\u1ecfe kh\u00e1c c\u1ee7a b\u1ea1n s\u1ebd quy\u1ebft \u0111\u1ecbnh b\u1ea1n n\u00ean l\u00e0m c\u00e1c x\u00e9t nghi\u1ec7m n\u00e0o. H\u00e3y t\u00ecm hi\u1ec3u th\u00eam v\u1ec1 c\u00e1c th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc m\u00e0 b\u00e1c s\u0129 c\u00f3 th\u1ec3 khuy\u1ebfn ngh\u1ecb cho b\u1ea1n nh\u00e9.  Ung th\u01b0 vu\u0301 Vi\u1ec7c ph\u00e1t hi\u1ec7n ung th\u01b0 vu\u0301 s\u1edbm c\u00f3 th\u1ec3 c\u1ea3i thi\u1ec7n \u0111\u00e1ng k\u1ec3 t\u1ec9 l\u1ec7 s\u1ed1ng s\u00f3t c\u1ee7a b\u1ea1n \u0111\u1ea5y. \u0110\u00f3 l\u00e0 v\u00ec khi ung th\u01b0 \u0111\u01b0\u1ee3c ph\u00e1t hi\u1ec7n c\u00e0ng nh\u1ecf th\u00ec c\u01a1 h\u1ed9i ch\u1eefa l\u00e0nh b\u1eb1ng ph\u1eabu thu\u1eadt c\u00e0ng nhi\u1ec1u. C\u00e1c kh\u1ed1i ung th\u01b0 vu\u0301 nh\u1ecf h\u01a1n cu\u0303ng th\u01b0\u1eddng \u00edt ph\u00e1t t\u00e1n, l\u00e2y lan \u0111\u1ebfn c\u00e1c h\u1ea1ch b\u1ea1ch huy\u1ebft v\u00e0 c\u00e1c c\u01a1 quan kh\u00e1c nh\u01b0 ph\u1ed5i v\u00e0 n\u00e3o h\u01a1n. N\u1ebfu b\u1ea1n \u0111ang \u1edf tu\u1ed5i 20 ho\u1eb7c 30 v\u00e0 ch\u01b0a h\u1ec1 bi\u1ebft c\u00e1c y\u1ebfu t\u1ed1 r\u1ee7i ro c\u1ee7a ch\u1ee9ng ung th\u01b0 vu\u0301 th\u00ec n\u00ean kh\u00e1m nhu\u0303 l\u00e2m s\u00e0ng \u1edf m\u1ed9t chuy\u00ean gia s\u1ee9c kh\u1ecfe n\u00e0o \u0111\u00f3 trong c\u00e1c l\u1ea7n kh\u00e1m s\u1ee9c kh\u1ecfe \u0111\u1ecbnh k\u1ef3 c\u1ee7a b\u1ea1n c\u1ee9 ba n\u0103m m\u1ed9t l\u1ea7n nh\u00e9.\u00a0  Th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc b\u1eb1ng ph\u01b0\u01a1ng ph\u00e1p ch\u1ee5p X-quang vu\u0300ng nhu\u0303  H\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn v\u1edbi b\u00e1c s\u0129 v\u1ec1 ph\u01b0\u01a1ng ph\u00e1p th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc ung th\u01b0 vu\u0301. Hi\u1ec7p h\u1ed9i Ung th\u01b0 Hoa K\u1ef3 khuy\u1ebfn c\u00e1o ph\u1ee5 n\u1eef c\u00f3 nguy c\u01a1 m\u1eafc b\u1ec7nh trung b\u00ecnh n\u00ean x\u00e9t nghi\u1ec7m s\u00e0ng l\u1ecdc h\u1eb1ng n\u0103m khi b\u1eaft \u0111\u1ea7u \u1edf tu\u1ed5i 40. Tuy nhi\u00ean, \u0110\u1ed9i \u0110\u1eb7c nhi\u1ec7m c\u00e1c D\u1ecbch v\u1ee5 Ng\u1eeba b\u1ec7nh Hoa K\u1ef3 l\u1ea1i khuy\u1ebfn ngh\u1ecb n\u00ean ch\u1ee5p X quang s\u00e0ng l\u1ecdc kh\u1ed1i u \u1edf ng\u1ef1c c\u1ee9 2 n\u0103m m\u1ed9t l\u1ea7n trong giai \u0111o\u1ea1n t\u1eeb 50 \u0111\u1ebfn 74 tu\u1ed5i. Nh\u1eefng tia X li\u1ec1u th\u1ea5p n\u00e0y c\u00f3 th\u1ec3 ph\u00e1t hi\u1ec7n ra kh\u1ed1i u 3 n\u0103m tr\u01b0\u1edbc khi b\u1ea1n c\u00f3 th\u1ec3 s\u1edd th\u1ea5y n\u00f3. Nh\u01b0ng ph\u01b0\u01a1ng ph\u00e1p ch\u1ee5p X quang kh\u1ed1i u ng\u1ef1c b\u00ecnh th\u01b0\u1eddng kh\u00f4ng ho\u00e0n to\u00e0n lo\u1ea1i b\u1ecf kh\u1ea3 n\u0103ng ung th\u01b0 vu\u0301.\u00a0\u00a0  Ung th\u01b0 c\u1ed5 t\u1eed cung C\u1ed5 t\u1eed cung l\u00e0 m\u1ed9t ph\u1ea7n c\u1ee7a t\u1eed cung n\u1eb1m k\u00e9o d\u00e0i xu\u1ed1ng khoang \u00e2m \u0111\u1ea1o. Ch\u1ee9ng nhi\u1ec5m vi ru\u0301t g\u00e2y b\u1ec7nh m\u1ee5n c\u01a1m tr\u00ean ng\u01b0\u1eddi (HPV) dai d\u1eb3ng l\u00e0 y\u1ebfu t\u1ed1 nguy hi\u1ec3m ch\u1ee7 y\u1ebfu \u0111\u1ed1i v\u1edbi b\u1ec7nh ung th\u01b0 c\u1ed5 t\u1eed cung. Ph\u01b0\u01a1ng ph\u00e1p th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc \u0111\u1ecbnh k\u1ef3 c\u00f3 th\u1ec3 ph\u00e1t hi\u1ec7n ra vi ru\u0301t n\u00e0y s\u1edbm,\u00a0 khi \u1ea5y ng\u01b0\u1eddi ta c\u00f3 th\u1ec3 ch\u1eefa l\u00e0nh m\u1ed9t c\u00e1ch d\u1ec5 d\u00e0ng. Ngo\u00e0i ra, n\u00f3 c\u00f2n giu\u0301p ph\u00e1t hi\u1ec7n c\u00e1c t\u1ebf b\u00e0o ti\u1ec1n ung th\u01b0 b\u1ea5t th\u01b0\u1eddng tr\u00ean b\u1ec1 m\u1eb7t c\u1ed5 t\u1eed cung v\u00ec v\u1eady ng\u01b0\u1eddi ta c\u00f3 th\u1ec3 c\u1eaft b\u1ecf \u0111i tr\u01b0\u1edbc khi chu\u0301ng bi\u1ebfn th\u00e0nh t\u1ebf b\u00e0o ung th\u01b0.  Th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc ung th\u01b0 c\u1ed5 t\u1eed cung B\u00e1c s\u0129 s\u1ebd l\u00e0m x\u00e9t nghi\u1ec7m Pap (x\u00e9t nghi\u1ec7m ph\u1ebft t\u1ebf b\u00e0o c\u1ed5 t\u1eed cung) \u0111\u1ec3 s\u00e0ng l\u1ecdc ung th\u01b0 c\u1ed5 t\u1eed cung. M\u1eabu t\u1ebf b\u00e0o c\u1ed5 t\u1eed cung c\u1ee7a b\u1ea1n \u0111\u01b0\u1ee3c l\u1ea5y t\u1ea1i ph\u00f2ng kh\u00e1m v\u00e0 chuy\u1ec3n \u0111\u1ebfn l\u00e0m x\u00e9t nghi\u1ec7m trong ph\u00f2ng th\u00ed nghi\u1ec7m \u0111\u1ec3 t\u00ecm t\u1ebf b\u00e0o ti\u1ec1n ung th\u01b0 v\u00e0 ung th\u01b0. Ph\u1ee5 n\u1eef n\u00ean l\u00e0m th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc l\u1ea7n \u0111\u1ea7u ti\u00ean \u1edf tu\u1ed5i 21. Ph\u01b0\u01a1ng ph\u00e1p n\u00e0y r\u1ea5t hi\u1ec7u qu\u1ea3 v\u1eeba \u0111\u1ec3 ph\u00f2ng tr\u00e1nh v\u1eeba \u0111\u1ec3 ph\u00e1t hi\u1ec7n ung th\u01b0 c\u1ed5 t\u1eed cung s\u1edbm \u0111\u1ec3 c\u00f3 th\u1ec3 \u0111i\u1ec1u tr\u1ecb k\u1ecbp th\u1eddi.  V\u1eafc-xin ng\u1eeba ung th\u01b0 c\u1ed5 t\u1eed cung FDA \u0111\u00e3 duy\u1ec7t v\u1eafc-xin Gardasil ng\u1eeba ung th\u01b0 c\u1ed5 t\u1eed cung cho ph\u1ee5 n\u1eef v\u00e0 b\u00e9 g\u00e1i \u1edf \u0111\u1ed9 tu\u1ed5i t\u1eeb 9 \u0111\u1ebfn 26. Gardasil t\u1ea1o mi\u1ec5n d\u1ecbch kh\u00e1ng 4 d\u00f2ng vi ru\u0301t HPV, l\u00e0 nguy\u00ean nh\u00e2n ch\u00ednh g\u00e2y ung th\u01b0 c\u1ed5 t\u1eed cung. V\u1eafc-xin th\u1ee9 2 l\u00e0 Cervarix, cu\u0303ng \u0111\u01b0\u1ee3c FDA \u0111\u1ed3ng \u00fd cho \u0111\u01b0a v\u00e0o s\u1eed d\u1ee5ng h\u1ed3i th\u00e1ng 10 n\u0103m 2009 \u0111\u1ed1i v\u1edbi b\u00e9 g\u00e1i v\u00e0 ph\u1ee5 n\u1eef \u1edf \u0111\u1ed9 tu\u1ed5i t\u1eeb 10 \u0111\u1ebfn 25. Cervarix c\u00f3 th\u1ec3 kh\u00e1ng 2 d\u00f2ng vi ru\u0301t HPV. Kh\u00f4ng ph\u1ea3i t\u1ea5t c\u1ea3 c\u00e1c tr\u01b0\u1eddng h\u1ee3p ung th\u01b0 c\u1ed5 t\u1eed cung cu\u0303ng \u0111\u1ec1u do HPV g\u00e2y ra v\u00e0 c\u00e1c d\u00f2ng HPV kh\u00e1c cu\u0303ng c\u00f3 th\u1ec3 l\u00e0 nguy\u00ean nh\u00e2n g\u00e2y ra ung th\u01b0 m\u00e0 kh\u00f4ng m\u1ed9t v\u1eafc xin n\u00e0o k\u1ec3 tr\u00ean c\u00f3 th\u1ec3 kh\u00e1ng \u0111\u01b0\u1ee3c. V\u00ec v\u1eady trong khi c\u00e1c v\u1eafc-xin n\u00e0y c\u00f3 th\u1ec3 l\u00e0m gi\u1ea3m \u0111\u00e1ng k\u1ec3 c\u00e1c tr\u01b0\u1eddng h\u1ee3p ung th\u01b0 c\u1ed5 t\u1eed cung, th\u00ec vi\u1ec7c l\u00e0m x\u00e9t nghi\u1ec7m Pap \u0111\u1ecbnh k\u1ef3 cu\u0303ng h\u1ebft s\u1ee9c quan tr\u1ecdng trong vi\u1ec7c s\u00e0ng l\u1ecdc ung th\u01b0 c\u1ed5 t\u1eed cung.  Lo\u00e3ng x\u01b0\u01a1ng v\u00e0 x\u01b0\u01a1ng b\u1ecb g\u00e3y  Lo\u00e3ng x\u01b0\u01a1ng l\u00e0 ch\u1ee9ng b\u1ec7nh m\u00e0 trong \u0111\u00f3 x\u01b0\u01a1ng tr\u1edf n\u00ean suy y\u1ebfu v\u00e0 d\u1ec5 g\u00e3y. Nguy\u00ean nh\u00e2n g\u00e2y lo\u00e3ng x\u01b0\u01a1ng l\u00e0 t\u00ecnh tr\u1ea1ng hao x\u01b0\u01a1ng (gi\u1ea3m kh\u1ed1i x\u01b0\u01a1ng), hi\u1ec7n t\u01b0\u1ee3ng n\u00e0y x\u1ea3y ra nhi\u1ec1u h\u01a1n \u1edf ph\u1ee5 n\u1eef th\u1eddi h\u1eadu m\u00e3n kinh. Tri\u1ec7u ch\u1ee9ng \u0111\u1ea7u ti\u00ean th\u01b0\u1eddng l\u00e0 n\u1ee9t x\u01b0\u01a1ng g\u00e2y \u0111au \u0111\u1edbn c\u00f3 th\u1ec3 x\u1ea3y ra khi ch\u1ec9 b\u1ecb t\u00e9, b\u1ecb \u0111\u00e1nh nh\u1eb9, ho\u1eb7c th\u1eadm ch\u00ed l\u00e0 ch\u1ec9 v\u1eb7n nh\u1eb9 ng\u01b0\u1eddi. T\u1ed5 ch\u1ee9c Lo\u00e3ng x\u01b0\u01a1ng Qu\u1ed1c gia cho bi\u1ebft ng\u01b0\u1eddi ta c\u00f3 th\u1ec3 v\u1eeba ph\u00f2ng tr\u00e1nh v\u1eeba ch\u1eefa l\u00e0nh ch\u1ee9ng lo\u00e3ng x\u01b0\u01a1ng \u2013 m\u1ed9t ch\u1ee9ng b\u1ec7nh \u0111e do\u1ea1 h\u01a1n ph\u00e2n n\u1eeda ng\u01b0\u1eddi l\u1edbn tu\u1ed5i t\u1eeb 50 tr\u1edf l\u00ean \u1edf M\u1ef9.  Th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng X\u00e9t nghi\u1ec7m h\u1ea5p th\u1ee5 tia X n\u0103ng l\u01b0\u1ee3ng k\u00e9p (DXA) c\u00f3 th\u1ec3 \u0111o \u0111\u01b0\u1ee3c m\u1eadt \u0111\u1ed9 ch\u1ea5t kho\u00e1ng trong x\u01b0\u01a1ng v\u00e0 ph\u00e1t hi\u1ec7n b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng tr\u01b0\u1edbc khi n\u1ee9t x\u01b0\u01a1ng. Ph\u01b0\u01a1ng ph\u00e1p n\u00e0y cu\u0303ng c\u00f3 th\u1ec3 giu\u0301p b\u00e1o tr\u01b0\u1edbc nguy c\u01a1 n\u1ee9t x\u01b0\u01a1ng c\u00f3 th\u1ec3 x\u1ea3y ra v\u1ec1 sau. X\u00e9t nghi\u1ec7m m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng cu\u0303ng \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb \u0111\u1ed1i v\u1edbi t\u1ea5t c\u1ea3 ph\u1ee5 n\u1eef t\u1eeb 65 tu\u1ed5i tr\u1edf l\u00ean, \u0111\u1ed3ng th\u1eddi cho ph\u1ee5 n\u1eef \u1edf tu\u1ed5i trung ni\u00ean d\u01b0\u1edbi 65 c\u00f3 nguy c\u01a1 m\u1eafc ch\u1ee9ng lo\u00e3ng x\u01b0\u01a1ng.  Ung th\u01b0 da D\u1ea1ng ung th\u01b0 da nguy hi\u1ec3m nh\u1ea5t l\u00e0 ung th\u01b0 da melanoma (h\u1eafc t\u1ed1/\u00e1c t\u00ednh). \u0110\u00e2y l\u00e0 d\u1ea1ng ung th\u01b0 da \u00e1c t\u00ednh g\u00e2y \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn c\u00e1c t\u1ebf b\u00e0o t\u1ea1o m\u00e0u tr\u00ean da. M\u1ed9t s\u1ed1 ng\u01b0\u1eddi c\u00f3 th\u1ec3 c\u00f3 nguy c\u01a1 ung th\u01b0 da melanoma di truy\u1ec1n v\u00e0 nguy c\u01a1 m\u1eafc b\u1ec7nh t\u1ec9 l\u1ec7 thu\u1eadn v\u1edbi t\u1ea7n s\u1ed1 ti\u1ebfp xu\u0301c v\u1edbi \u00e1nh n\u1eafng m\u1eb7t tr\u1eddi v\u00e0 ch\u00e1y n\u1eafng. Ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb ung th\u01b0 da s\u1edbm c\u00f3 th\u1ec3 r\u1ea5t hi\u1ec7u qu\u1ea3. C\u00e1c kh\u1ed1i u \u00e1c t\u00ednh \u0111\u01b0\u1ee3c ph\u00e1t hi\u1ec7n \u1edf giai \u0111o\u1ea1n nh\u1eb9 h\u01a1n c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c \u0111i\u1ec1u tr\u1ecb th\u00e0nh c\u00f4ng h\u01a1n so v\u1edbi c\u00e1c kh\u1ed1i u d\u00e0y \u0111\u00e3 ph\u00e1t tri\u1ec3n \u0103n s\u00e2u v\u00e0o da. Ung th\u01b0 t\u1ebf b\u00e0o \u0111\u00e1y v\u00e0 t\u1ebf b\u00e0o c\u00f3 v\u1ea3y da l\u00e0 d\u1ea1ng ung th\u01b0 da kh\u00f4ng h\u1eafc t\u1ed1 th\u01b0\u1eddng th\u1ea5y.  X\u00e9t nghi\u1ec7m s\u00e0ng l\u1ecdc ung th\u01b0 da Hi\u1ec7p h\u1ed9i Ung th\u01b0 v\u00e0 Vi\u1ec7n Da li\u1ec5u Hoa K\u1ef3 khuy\u1ebfn ngh\u1ecb n\u00ean t\u1ef1 ki\u1ec3m tra da th\u01b0\u1eddng xuy\u00ean \u0111\u1ec3 nh\u1eb1m ph\u00e1t hi\u1ec7n ra b\u1ea5t k\u1ef3 s\u1ef1 thay \u0111\u1ed5i n\u00e0o tr\u00ean da nh\u01b0 h\u00ecnh d\u1ea1ng, m\u00e0u da, v\u00e0 k\u00edch th\u01b0\u1edbc da. Ngo\u00e0i ra cu\u0303ng n\u00ean kh\u00e1m da \u1edf b\u00e1c s\u0129 da li\u1ec5u hay c\u00e1c chuy\u00ean gia s\u1ee9c kho\u1ebb kh\u00e1c trong nh\u1eefng l\u1ea7n ki\u1ec3m tra s\u1ee9c kh\u1ecfe ph\u00e1t hi\u1ec7n ung th\u01b0 \u0111\u1ecbnh k\u1ef3. Cao huy\u1ebft \u00e1p (T\u0103ng huy\u1ebft \u00e1p) Nguy c\u01a1 cao huy\u1ebft \u00e1p t\u1ec9 l\u1ec7 thu\u1eadn v\u1edbi tu\u1ed5i t\u00e1c. N\u00f3 cu\u0303ng li\u00ean quan \u0111\u1ebfn ch\u1ec9 s\u1ed1 c\u00e2n n\u1eb7ng v\u00e0 l\u1ed1i s\u1ed1ng c\u1ee7a b\u1ea1n. B\u1ec7nh cao huy\u1ebft \u00e1p cu\u0303ng c\u00f3 th\u1ec3 g\u00e2y ra nhi\u1ec1u bi\u1ebfn ch\u1ee9ng nguy hi\u1ec3m m\u00e0 kh\u00f4ng c\u00f3 tri\u1ec7u ch\u1ee9ng b\u00e1o tr\u01b0\u1edbc, nh\u01b0 ch\u1ee9ng ph\u00ecnh m\u1ea1ch. Nh\u01b0ng b\u1ec7nh n\u00e0y c\u00f3 th\u1ec3 ch\u1eefa tr\u1ecb \u0111\u01b0\u1ee3c. Khi m\u1eafc ch\u1ee9ng b\u1ec7nh n\u00e0y, b\u1ea1n c\u00f3 th\u1ec3 gi\u1ea3m nguy c\u01a1 b\u1ec7nh tim, \u0111\u1ed9t qu\u1ef5, v\u00e0 suy th\u1eadn. \u0110i\u1ec1u quan tr\u1ecdng l\u00e0 b\u1ea1n n\u00ean hi\u1ec3u bi\u1ebft v\u1ec1 ch\u1ee9ng cao huy\u1ebft \u00e1p c\u1ee7a m\u00ecnh. N\u1ebfu b\u1ea1n b\u1ecb cao huy\u1ebft \u00e1p th\u00ec h\u00e3y tham kh\u1ea3o v\u1edbi b\u00e1c s\u0129, h\u1ee3p t\u00e1c v\u1edbi b\u00e1c s\u0129 \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb nh\u00e9.\u00a0  X\u00e9t nghi\u1ec7m s\u00e0ng l\u1ecdc ch\u1ee9ng cao huy\u1ebft \u00e1p  S\u1ed1 \u0111o huy\u1ebft \u00e1p g\u1ed3m 2 ch\u1eef s\u1ed1. Ch\u1eef s\u1ed1 \u0111\u1ea7u ti\u00ean (t\u00e2m thu) l\u00e0 \u00e1p l\u1ef1c m\u00e1u so v\u1edbi th\u00e0nh \u0111\u1ed9ng m\u1ea1ch khi tim \u0111\u1eadp. Ch\u1eef s\u1ed1 th\u1ee9 hai (t\u00e2m tr\u01b0\u01a1ng) l\u00e0 \u00e1p su\u1ea5t gi\u1eefa c\u00e1c nh\u1ecbp \u0111\u1eadp. Huy\u1ebft \u00e1p \u1edf ng\u01b0\u1eddi l\u1edbn b\u00ecnh th\u01b0\u1eddng d\u01b0\u1edbi 120/80. Huy\u1ebft \u00e1p cao l\u00e0 140/90 tr\u1edf l\u00ean, v\u00e0 gi\u1eefa hai ch\u1ec9 s\u1ed1 \u0111\u00f3 l\u00e0 ti\u1ec1n huy\u1ebft \u00e1p. T\u1ea7n s\u1ed1 ki\u1ec3m tra, \u0111o huy\u1ebft \u00e1p tu\u1ef3 thu\u1ed9c v\u00e0o s\u1ed1 \u0111o huy\u1ebft \u00e1p c\u1ee7a ng\u01b0\u1eddi b\u1ec7nh l\u00e0 bao nhi\u00eau v\u00e0 c\u00e1c y\u1ebfu t\u1ed1 nguy hi\u1ec3m kh\u00e1c.\u00a0  N\u1ed3ng \u0111\u1ed9 cholesterol N\u1ed3ng \u0111\u1ed9 cholesterol LDL cao l\u00e0 nguy\u00ean nh\u00e2n ch\u00ednh l\u00e0m t\u0103ng nguy c\u01a1 ph\u00e1t tri\u1ec3n b\u1ec7nh tim v\u00e0 x\u01a1 v\u1eefa \u0111\u1ed9ng m\u1ea1ch - l\u00e0m h\u1eb9p v\u00e0 x\u01a1 c\u1ee9ng \u0111\u1ed9ng m\u1ea1ch \u2013 g\u00e2y ra do t\u0103ng sinh m\u1ea3ng b\u00e1m b\u00ean trong \u0111\u1ed9ng m\u1ea1ch. N\u00f3 c\u00f3 th\u1ec3 ph\u00e1t tri\u1ec3n m\u00e0 kh\u00f4ng h\u1ec1 b\u1ed9c l\u1ed9 b\u1ea5t k\u1ef3 tri\u1ec7u ch\u1ee9ng g\u00ec trong nhi\u1ec1u n\u0103m. D\u1ea7n d\u1ea7n b\u1ec7nh n\u00e0y c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn \u0111au tim v\u00e0 \u0111\u1ed9t qu\u1ef5. C\u00e1c nguy c\u01a1 g\u00e2y x\u01a1 v\u1eefa \u0111\u1ed9ng m\u1ea1ch kh\u00e1c l\u00e0 cao huy\u1ebft \u00e1p, ti\u1ec3u \u0111\u01b0\u1eddng, v\u00e0 thu\u1ed1c l\u00e1. Vi\u1ec7c thay \u0111\u1ed5i l\u1ed1i s\u1ed1ng v\u00e0 thu\u1ed1c c\u00f3 th\u1ec3 l\u00e0m gi\u1ea3m nguy c\u01a1 b\u1ec7nh tim m\u1ea1ch c\u1ee7a b\u1ea1n \u0111\u1ea5y.  X\u00e1c \u0111\u1ecbnh n\u1ed3ng \u0111\u1ed9 cholesterol B\u00e1c s\u0129 s\u00e0ng l\u1ecdc v\u1ea5n \u0111\u1ec1 cholesterol b\u1eb1ng ph\u01b0\u01a1ng ph\u00e1p x\u00e9t nghi\u1ec7m m\u1ee1 m\u00e1u lu\u0301c \u0111\u00f3i. \u0110\u00e2y l\u00e0 m\u1ed9t x\u00e9t nghi\u1ec7m m\u00e1u c\u00f3 th\u1ec3 cho b\u1ea1n bi\u1ebft n\u1ed3ng \u0111\u1ed9 cholesterol to\u00e0n ph\u1ea7n c\u1ee7a m\u00ecnh, cholesterol LDL \u201cx\u1ea5u\u201d, cholesterol HDL \u201ct\u1ed1t\u201d, v\u00e0 li-p\u00edt trung t\u00ednh (m\u1ee1 m\u00e1u). B\u00e1c s\u0129 s\u1ebd l\u1ef1a ch\u1ecdn ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb nh\u01b0 th\u1ebf n\u00e0o tu\u1ef3 thu\u1ed9c v\u00e0o k\u1ebft qu\u1ea3 c\u1ee7a b\u1ea1n. Ng\u01b0\u1eddi l\u1edbn t\u1eeb 20 tu\u1ed5i tr\u1edf l\u00ean n\u00ean x\u00e9t nghi\u1ec7m m\u1ee1 m\u00e1u \u00edt nh\u1ea5t 5 n\u0103m m\u1ed9t l\u1ea7n.  Ti\u1ec3u \u0111\u01b0\u1eddng lo\u1ea1i 2 1/3 ng\u01b0\u1eddi M\u1ef9 b\u1ecb ti\u1ec3u \u0111\u01b0\u1eddng m\u00e0 kh\u00f4ng bi\u1ebft. \u0110\u00e2y l\u00e0 nguy\u00ean nh\u00e2n g\u00e2y t\u1eed vong th\u1ee9 6 \u1edf \u0111\u1ea5t n\u01b0\u1edbc n\u00e0y, ti\u1ec3u \u0111\u01b0\u1eddng c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn r\u1ea5t nhi\u1ec1u bi\u1ebfn ch\u1ee9ng nh\u01b0 b\u1ec7nh tim v\u00e0 \u0111\u1ed9t qu\u1ef5, b\u1ec7nh th\u1eadn, mu\u0300 m\u1eaft do t\u1ed5n th\u01b0\u01a1ng m\u1ea1ch m\u00e1u v\u00f5ng, v\u00e0 t\u1ed5n h\u1ea1i th\u1ea7n kinh. Nh\u01b0ng \u0111i\u1ec1u n\u00e0y c\u00f3 th\u1ec3 tr\u00e1nh \u0111\u01b0\u1ee3c, nh\u1ea5t l\u00e0 khi \u0111\u01b0\u1ee3c ph\u00e1t hi\u1ec7n s\u1edbm, ng\u01b0\u1eddi ta c\u00f3 th\u1ec3 \u0111i\u1ec1u tr\u1ecb \u0111\u01b0\u1ee3c ti\u1ec3u \u0111\u01b0\u1eddng v\u00e0 c\u00f3 th\u1ec3 tr\u00e1nh \u0111\u01b0\u1ee3c c\u00e1c bi\u1ebfn ch\u1ee9ng b\u1eb1ng c\u00e1ch \u0103n ki\u00eang, t\u1eadp th\u1ec3 d\u1ee5c, v\u00e0 ch\u1ebf \u0111\u1ed9 gi\u1ea3m c\u00e2n.\u00a0  X\u00e9t nghi\u1ec7m s\u00e0ng l\u1ecdc b\u1ec7nh ti\u1ec3u \u0111\u01b0\u1eddng lo\u1ea1i 2 Ph\u01b0\u01a1ng ph\u00e1p x\u00e9t nghi\u1ec7m \u0111\u01b0\u1eddng glu-c\u00f4 huy\u1ebft t\u01b0\u01a1ng lu\u0301c \u0111\u00f3i th\u01b0\u1eddng \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng nh\u1ea5t \u0111\u1ec3 s\u00e0ng l\u1ecdc b\u1ec7nh ti\u1ec3u \u0111\u01b0\u1eddng v\u00e0 ti\u1ec1n ti\u1ec3u \u0111\u01b0\u1eddng. Sau khi b\u1ea1n nh\u1ecbn \u0103n \u00edt nh\u1ea5t 8 ti\u1ebfng \u0111\u1ed3ng h\u1ed3, b\u00e1c s\u0129 s\u1ebd l\u1ea5y m\u00e1u v\u00e0 m\u1eabu m\u00e1u n\u00e0y \u0111\u01b0\u1ee3c du\u0300ng \u0111\u1ec3 x\u00e1c \u0111\u1ecbnh n\u1ed3ng \u0111\u1ed9 \u0111\u01b0\u1eddng huy\u1ebft c\u1ee7a b\u1ea1n. N\u1ed3ng \u0111\u1ed9 t\u1eeb 100 \u0111\u1ebfn 125 cho bi\u1ebft d\u1ea5u hi\u1ec7u ti\u1ec1n ti\u1ec3u \u0111\u01b0\u1eddng, v\u00e0 t\u1eeb 126 tr\u1edf l\u00ean l\u00e0 \u0111\u00e3 b\u1ecb ti\u1ec3u \u0111\u01b0\u1eddng. N\u1ebfu b\u1ea1n kh\u1ecfe m\u1ea1nh v\u00e0 c\u00f3 nguy c\u01a1 m\u1eafc b\u1ec7nh ti\u1ec3u \u0111\u01b0\u1eddng b\u00ecnh th\u01b0\u1eddng th\u00ec n\u00ean l\u00e0m x\u00e9t nghi\u1ec7m c\u1ee9 3\u00a0 n\u0103m m\u1ed9t l\u1ea7n khi m\u1edbi b\u1eaft \u0111\u1ea7u \u1edf tu\u1ed5i 45. N\u1ebfu b\u1ea1n c\u00f3 nguy c\u01a1 cao h\u01a1n th\u00ec c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u x\u00e9t nghi\u1ec7m s\u1edbm h\u01a1n v\u00e0 th\u01b0\u1eddng xuy\u00ean h\u01a1n.  Vi-ru\u0301t HIV  HIV l\u00e0 vi ru\u0301t g\u00e2y b\u1ec7nh AIDS. HIV trong m\u00e1u v\u00e0 c\u00e1c d\u1ecbch ti\u1ebft kh\u00e1c c\u1ee7a c\u01a1 th\u1ec3 ng\u01b0\u1eddi b\u1ec7nh, th\u1eadm ch\u00ed t\u1ed3n t\u1ea1i vi ru\u0301t HIV khi kh\u00f4ng c\u00f3 tri\u1ec7u ch\u1ee9ng g\u00ec. Vi ru\u0301t n\u00e0y ph\u00e1t t\u00e1n, l\u00e2y lan t\u1eeb ng\u01b0\u1eddi n\u00e0y sang ng\u01b0\u1eddi kh\u00e1c khi nh\u1eefng d\u1ecbch ti\u1ebft n\u00e0y ti\u1ebfp xu\u0301c v\u1edbi \u00e2m \u0111\u1ea1o, vu\u0300ng h\u1eadu m\u00f4n, mi\u1ec7ng, m\u1eaft, ho\u1eb7c m\u1ed9t v\u1ebft r\u00e1ch tr\u00ean da. Ng\u01b0\u1eddi ta v\u1eabn ch\u01b0a t\u00ecm ra v\u1eafc-xin ho\u1eb7c thu\u1ed1c tr\u1ecb b\u1ec7nh AIDS. Nh\u01b0ng, v\u1ec1 m\u1eb7t l\u00fd thuy\u1ebft m\u00e0 n\u00f3i th\u00ec ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb s\u1edbm b\u1eb1ng thu\u1ed1c kh\u00e1ng vi ru\u0301t HIV cu\u0303ng c\u00f3 th\u1ec3 giu\u0301p h\u1ec7 mi\u1ec5n d\u1ecbch c\u01a1 th\u1ec3 ch\u1ed1ng l\u1ea1i \u0111\u01b0\u1ee3c vi ru\u0301t.  X\u00e9t nghi\u1ec7m s\u00e0ng l\u1ecdc HIV Ng\u01b0\u1eddi b\u1ecb nhi\u1ec5m HIV c\u00f3 th\u1ec3 v\u1eabn kh\u00f4ng b\u1ed9c ph\u00e1t tri\u1ec7u ch\u1ee9ng g\u00ec trong nhi\u1ec1u n\u0103m. C\u00e1ch duy nh\u1ea5t \u0111\u1ec3 nh\u1eadn bi\u1ebft l\u00e0 m\u1ed9t lo\u1ea1t c\u00e1c x\u00e9t nghi\u1ec7m m\u00e1u. X\u00e9t nghi\u1ec7m \u0111\u1ea7u ti\u00ean c\u00f3 t\u00ean l\u00e0 ELISA ho\u1eb7c EIA. X\u00e9t nghi\u1ec7m n\u00e0y t\u00ecm kh\u00e1ng th\u1ec3 kh\u00e1ng HIV trong m\u00e1u. Ng\u01b0\u1eddi ta c\u00f3 th\u1ec3 kh\u00f4ng b\u1ecb nhi\u1ec5m HIV nh\u01b0ng v\u1eabn c\u00f3 k\u1ebft qu\u1ea3 x\u00e9t nghi\u1ec7m d\u01b0\u01a1ng t\u00ednh. V\u00ec v\u1eady ph\u1ea3i ti\u1ebfn h\u00e0nh m\u1ed9t x\u00e9t nghi\u1ec7m th\u1ee9 hai \u0111\u1ec3 x\u00e1c nh\u1eadn l\u1ea1i, g\u1ecdi l\u00e0 x\u00e9t nghi\u1ec7m k\u1ef9 thu\u1eadt t\u00e1ch pr\u00f4-t\u00ea-in. N\u1ebfu b\u1ea1n m\u1edbi b\u1ecb nhi\u1ec5m vi ru\u0301t th\u00ec k\u1ebft qu\u1ea3 x\u00e9t nghi\u1ec7m c\u1ee7a b\u1ea1n c\u00f3 th\u1ec3 v\u1eabn l\u00e0 \u00e2m t\u00ednh. B\u1ea1n n\u00ean l\u00e0m l\u1ea1i x\u00e9t nghi\u1ec7m nh\u00e9. N\u1ebfu b\u1ea1n ngh\u0129 m\u00ecnh \u0111\u00e3 ti\u1ebfp xu\u0301c v\u1edbi vi ru\u0301t HIV, th\u00ec h\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 c\u00e1c x\u00e9t nghi\u1ec7m n\u00e0y nh\u00e9.  Ng\u0103n ng\u1eeba l\u00e2y lan HIV H\u1ea7u h\u1ebft c\u00e1c tr\u01b0\u1eddng h\u1ee3p m\u1edbi nhi\u1ec5m vi ru\u0301t \u0111\u1ec1u c\u00f3 k\u1ebft qu\u1ea3 d\u01b0\u01a1ng t\u00ednh sau 2 th\u00e1ng l\u00e2y b\u1ec7nh. Nh\u01b0ng c\u00f3 \u0111\u1ebfn 5% b\u1ec7nh nh\u00e2n v\u1eabn \u00e2m t\u00ednh sau 6 th\u00e1ng l\u00e2y nhi\u1ec5m. H\u00e0nh vi ki\u00eang quan h\u1ec7 t\u00ecnh d\u1ee5c ho\u1eb7c s\u1eed d\u1ee5ng m\u00e0ng ng\u0103n nh\u1ef1a m\u1ee7 nh\u01b0 bao cao su ho\u1eb7c m\u00e0ng ch\u1eafn nha khoa l\u00e0 r\u1ea5t c\u1ea7n thi\u1ebft trong vi\u1ec7c tr\u00e1nh l\u00e2y nhi\u1ec5m vi ru\u0301t HIV v\u00e0 c\u00e1c b\u1ec7nh l\u00e2y truy\u1ec1n qua \u0111\u01b0\u1eddng t\u00ecnh d\u1ee5c kh\u00e1c. N\u1ebfu b\u1ea1n nhi\u1ec5m vi ru\u0301t HIV trong khi \u0111ang c\u00f3 thai th\u00ec h\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn b\u00e1c s\u0129 v\u1ec1 nh\u1eefng \u0111i\u1ec1u n\u00ean l\u00e0m \u0111\u1ec3 l\u00e0m gi\u1ea3m nguy c\u01a1 l\u00e2y nhi\u1ec5m HIV sang cho thai nhi c\u1ee7a b\u1ea1n nh\u00e9. Ung th\u01b0 k\u1ebft tr\u00e0ng-tr\u1ef1c tr\u00e0ng Ung th\u01b0 k\u1ebft tr\u00e0ng-tr\u1ef1c tr\u00e0ng l\u00e0 nguy\u00ean nh\u00e2n g\u00e2y t\u1eed vong v\u00ec ung th\u01b0 th\u01b0\u1eddng th\u1ea5y th\u1ee9 hai v\u00e0 l\u00e0 ch\u1ee9ng ung th\u01b0 th\u1ee9 3 x\u1ea3y ra \u1edf ph\u1ee5 n\u1eef sau ung th\u01b0 ph\u1ed5i v\u00e0 ung th\u01b0 vu\u0301. Ph\u1ea7n l\u1edbn c\u00e1c tr\u01b0\u1eddng h\u1ee3p ung th\u01b0 \u0111\u1ea1i tr\u00e0ng ph\u00e1t sinh t\u1eeb p\u00f4-l\u00edp \u0111\u1ea1i tr\u00e0ng \u2013 nh\u1eefng kh\u1ed1i u n\u1eb1m tr\u00ean b\u1ec1 m\u1eb7t b\u00ean trong c\u1ee7a \u0111\u1ea1i tr\u00e0ng. Sau khi ung th\u01b0 ph\u00e1t tri\u1ec3n, n\u00f3 c\u00f3 th\u1ec3 x\u00e2m nh\u1eadp ho\u1eb7c l\u00e2y lan, ph\u00e1t t\u00e1n sang c\u00e1c b\u1ed9 ph\u1eadn kh\u00e1c c\u1ee7a c\u01a1 th\u1ec3. Ph\u01b0\u01a1ng ph\u00e1p ph\u00f2ng tr\u00e1nh ung th\u01b0 \u0111\u1ea1i tr\u00e0ng l\u00e0 d\u00f2 t\u00ecm, ph\u00e1t hi\u1ec7n ra v\u00e0 c\u1eaft b\u1ecf p\u00f4-l\u00edp \u0111\u1ea1i tr\u00e0ng tr\u01b0\u1edbc khi c\u00e1c p\u00f4-l\u00edp n\u00e0y bi\u1ebfn th\u00e0nh ung th\u01b0.  Th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc ung th\u01b0 \u0111\u1ea1i tr\u00e0ng-k\u1ebft tr\u00e0ng Soi k\u1ebft tr\u00e0ng l\u00e0 th\u1eed nghi\u1ec7m s\u00e0ng l\u1ecdc th\u01b0\u1eddng th\u1ea5y \u0111\u1ed1i v\u1edbi ch\u1ee9ng ung th\u01b0 k\u1ebft tr\u00e0ng-tr\u1ef1c tr\u00e0ng. B\u00e1c s\u0129 s\u1eed d\u1ee5ng m\u1ed9t m\u00e1y \u1ea3nh v\u00e0 \u1ed1ng m\u1ec1m \u0111\u1ec3 quan s\u00e1t t\u1ed5ng th\u1ec3 \u0111\u1ea1i tr\u00e0ng, \u0111\u1ed3ng th\u1eddi c\u00f3 th\u1ec3 c\u1eaft b\u1ecf p\u00f4-l\u00edp ngay lu\u0301c l\u00e0m x\u00e9t nghi\u1ec7m. Ng\u01b0\u1eddi ta cu\u0303ng c\u00f3 th\u1ec3 thay th\u1ebf b\u1eb1ng m\u1ed9t th\u1ee7 thu\u1eadt t\u01b0\u01a1ng t\u1ef1 \u0111\u00f3 l\u00e0 ph\u00e9p soi \u0111\u1ea1i tr\u00e0ng sigma \u1ed1ng m\u1ec1m ch\u1ec9 kh\u00e1m v\u00e0 ki\u1ec3m tra ph\u1ea7n d\u01b0\u1edbi c\u1ee7a \u0111\u1ea1i tr\u00e0ng. N\u1ebfu b\u1ea1n c\u00f3 nguy c\u01a1 m\u1eafc b\u1ec7nh trung b\u00ecnh th\u00ec th\u01b0\u1eddng n\u00ean l\u00e0m x\u00e9t nghi\u1ec7m lu\u0301c m\u1edbi b\u1eaft \u0111\u1ea7u \u1edf tu\u1ed5i 50.  T\u0103ng nh\u00e3n \u00e1p T\u0103ng nh\u00e3n \u00e1p l\u00e0 ch\u1ee9ng b\u1ec7nh c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn mu\u0300 m\u1eaft v\u00ec t\u1ed5n h\u1ea1i d\u00e2y th\u1ea7n kinh th\u1ecb gi\u00e1c. T\u0103ng nh\u00e3n \u00e1p g\u00f3c m\u1edf nguy\u00ean ph\u00e1t (T\u0103ng nh\u00e3n \u00e1p g\u00f3c m\u1edf ti\u00ean kh\u1edfi) l\u00e0 lo\u1ea1i th\u01b0\u1eddng th\u1ea5y nh\u1ea5t. Ch\u1ee9ng t\u0103ng nh\u00e3n \u00e1p n\u00e0y th\u01b0\u1eddng kh\u00f4ng bi\u1ec3u hi\u1ec7n tri\u1ec7u ch\u1ee9ng g\u00ec cho \u0111\u1ebfn khi qu\u00e1 mu\u1ed9n v\u00e0 \u0111\u00e3 b\u1eaft \u0111\u1ea7u m\u1ea5t th\u1ecb gi\u00e1c, kh\u00f4ng c\u00f2n nh\u00ecn r\u00f5 n\u1eefa. C\u00f3 m\u1ed9t b\u1eb1ng ch\u1ee9ng \u0111\u00e1ng tin c\u1eady l\u00e0 vi\u1ec7c \u0111i\u1ec1u tr\u1ecb \u00e1p su\u1ea5t m\u1eaft t\u0103ng trong b\u1ec7nh t\u0103ng nh\u00e3n \u00e1p c\u00f3 th\u1ec3 ph\u00f2ng tr\u00e1nh \u0111\u01b0\u1ee3c ch\u1ee9ng mu\u0300 m\u1eaft.  S\u00e0ng l\u1ecdc b\u1ec7nh t\u0103ng nh\u00e3n \u00e1p B\u1ea1n n\u00ean kh\u00e1m m\u1eaft g\u1ed3m c\u1ea3 \u0111o \u00e1p su\u1ea5t m\u1eaft bao l\u00e2u m\u1ed9t l\u1ea7n tu\u1ef3 thu\u1ed9c v\u00e0o y\u1ebfu t\u1ed1 tu\u1ed5i t\u00e1c v\u00e0 c\u00e1c nguy c\u01a1 r\u1ee7i ro kh\u00e1c c\u1ee7a b\u1ea1n. Ng\u01b0\u1eddi M\u1ef9 g\u1ed1c Phi, ng\u01b0\u1eddi gi\u00e0 tr\u00ean 60 tu\u1ed5i, ng\u01b0\u1eddi c\u00f3 ti\u1ec1n s\u1eed gia \u0111\u00ecnh b\u1ecb t\u0103ng nh\u00e3n \u00e1p, ng\u01b0\u1eddi c\u00f3 ti\u1ec1n s\u1eed b\u1ecb ch\u1ea5n th\u01b0\u01a1ng m\u1eaft, v\u00e0 ng\u01b0\u1eddi s\u1eed d\u1ee5ng steroid c\u00f3 nguy c\u01a1 m\u1eafc b\u1ec7nh cao. Ng\u01b0\u1eddi d\u01b0\u1edbi 40 tu\u1ed5i kh\u1ecfe m\u1ea1nh, kh\u00f4ng c\u00f3 nguy c\u01a1 cao th\u00ec n\u00ean l\u00e0m x\u00e9t nghi\u1ec7m \u0111\u1ecbnh k\u1ef3 c\u1ee9 2 \u0111\u1ebfn 4 n\u0103m m\u1ed9t l\u1ea7n. \u1ede \u0111\u1ed9 tu\u1ed5i t\u1eeb 40 \u0111\u1ebfn 54, ph\u1ee5 n\u1eef n\u00ean l\u00e0m x\u00e9t nghi\u1ec7m c\u1ee9 1 \u0111\u1ebfn 3 n\u0103m m\u1ed9t l\u1ea7n v\u00e0 t\u1eeb 55 \u0111\u1ebfn 64 c\u1ee9 1 \u0111\u1ebfn 2 n\u0103m m\u1ed9t l\u1ea7n, v\u00e0 ng\u01b0\u1eddi gi\u00e0 tr\u00ean 65 tu\u1ed5i c\u1ee9 6 \u0111\u1ebfn 12 th\u00e1ng m\u1ed9t l\u1ea7n.\u00a0  T\u1ea7m quan tr\u1ecdng c\u1ee7a x\u00e9t nghi\u1ec7m s\u00e0ng l\u1ecdc s\u1ee9c kh\u1ecfe Vi\u1ec7c ch\u1ee7 \u0111\u1ed9ng l\u00e0m x\u00e9t nghi\u1ec7m v\u00e0 tham kh\u1ea3o \u00fd ki\u1ebfn b\u00e1c s\u0129 v\u1ec1 c\u00e1c x\u00e9t nghi\u1ec7m c\u00f3 th\u1ec3 giu\u0301p b\u1ea1n b\u1ea3o v\u1ec7 s\u1ee9c kh\u1ecfe m\u00ecnh \u0111\u01b0\u1ee3c t\u1ed1t h\u01a1n. M\u1ed9t s\u1ed1 x\u00e9t nghi\u1ec7m, nh\u01b0 x\u00e9t nghi\u1ec7m Pap (ph\u1ebft t\u1ebf b\u00e0o c\u1ed5 t\u1eed cung) ho\u1eb7c kh\u00e1m nhu\u0303 n\u00ean \u0111\u01b0\u1ee3c th\u1ef1c hi\u1ec7n \u0111\u1ecbnh k\u1ef3 trong ch\u01b0\u01a1ng tr\u00ecnh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe c\u1ee7a ph\u1ee5 n\u1eef. C\u00e1c x\u00e9t nghi\u1ec7m kh\u00e1c l\u00e0 quan tr\u1ecdng h\u01a1n ho\u1eb7c k\u00e9m quan tr\u1ecdng h\u01a1n tu\u1ef3 thu\u1ed9c v\u00e0o nguy c\u01a1 m\u1eafc b\u1ec7nh c\u1ee7a b\u1ea1n. Ph\u01b0\u01a1ng ph\u00e1p x\u00e9t nghi\u1ec7m s\u00e0ng l\u1ecdc \u0111u\u0301ng \u0111\u1eafn kh\u00f4ng ph\u1ea3i lu\u0301c n\u00e0o cu\u0303ng c\u00f3 t\u00e1c d\u1ee5ng ph\u00f2ng tr\u00e1nh \u0111\u01b0\u1ee3c b\u1ec7nh t\u1eadt, nh\u01b0ng n\u00f3 c\u00f3 th\u1ec3 ph\u00e1t hi\u1ec7n ra b\u1ec7nh s\u1edbm k\u1ecbp th\u1eddi cho b\u1ea1n c\u00f3 th\u1ec3 \u0111i\u1ec1u tr\u1ecb v\u00e0 v\u01b0\u1ee3t quan m\u1ed9t c\u00e1ch t\u1ed1t nh\u1ea5t."
        }
    ],
    "suggestions": []
}